Unilever
UL · NYSESoap, Detergents, Cleang Preparations, Perfumes, Cosmetics · Fiscal year ends Dec 31 · Reports in EUR
Unilever reported revenue of EUR 50.5B in the fiscal year ended Dec 2025, down 3.8% from the year before. Operating income was EUR 9B, an operating margin of 17.9%, and net income was EUR 10B. Operating cash flow of EUR 8.4B less capital expenditure of EUR 1.4B left free cash flow of EUR 6.9B.
Last 5 fiscal years
Revenue and net income
Income statement
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue | EUR 52.4B | EUR 60.1B | EUR 51.7B | EUR 52.5B | EUR 50.5B |
| Cost of revenue | EUR 30.3B | EUR 35.9B | EUR 29.2B | EUR 28B | EUR 26.8B |
| Gross profit | EUR 22.2B | EUR 24.2B | EUR 22.5B | EUR 24.5B | EUR 23.7B |
| Research & development | EUR 847M | EUR 908M | EUR 853M | EUR 892M | EUR 836M |
| Selling, general & admin | EUR 12.5B | EUR 14.5B | EUR 13.4B | EUR 14.3B | EUR 13.6B |
| Operating income | EUR 8.7B | EUR 10.8B | EUR 9B | EUR 8.8B | EUR 9B |
| Interest expense | EUR 491M | EUR 818M | EUR 922M | EUR 994M | EUR 1B |
| Pre-tax income | EUR 8.6B | EUR 10.3B | EUR 8.6B | EUR 8.4B | EUR 8.7B |
| Income tax | EUR 1.9B | EUR 2.1B | EUR 2B | EUR 2.3B | EUR 2.5B |
| Net income | EUR 6.6B | EUR 8.3B | EUR 7.1B | EUR 6.4B | EUR 10B |
Balance sheet
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Cash & equivalents | EUR 3.4B | EUR 4.3B | EUR 4.2B | EUR 6.1B | EUR 3.9B |
| Receivables | EUR 5.4B | EUR 7.1B | EUR 5.8B | EUR 6B | EUR 7.3B |
| Inventory | EUR 4.7B | EUR 5.9B | EUR 5.1B | EUR 5.2B | EUR 4B |
| Current assets | EUR 17.4B | EUR 19.2B | EUR 17.9B | EUR 19.2B | EUR 17.1B |
| Net PP&E | EUR 10.3B | EUR 9.4B | EUR 9.4B | EUR 10.3B | EUR 7.8B |
| Goodwill | EUR 20.3B | EUR 21.6B | EUR 21.1B | EUR 22.3B | EUR 17.7B |
| Total assets | EUR 75.1B | EUR 77.8B | EUR 75.3B | EUR 79.8B | EUR 70.5B |
| Payables | EUR 14.9B | EUR 18B | EUR 16.9B | EUR 16.7B | EUR 16.9B |
| Current liabilities | EUR 24.8B | EUR 25.4B | EUR 23.5B | EUR 25.2B | EUR 21.7B |
| Total liabilities | EUR 55.3B | EUR 56.1B | EUR 54.5B | EUR 57.2B | EUR 52.9B |
| Shareholders' equity | EUR 17.1B | EUR 19B | EUR 18.1B | EUR 20B | EUR 15.5B |
Cash flow
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Operating cash flow | EUR 8B | EUR 7.3B | EUR 9.4B | EUR 9.5B | EUR 8.4B |
| Capital expenditure | EUR 1.1B | EUR 1.5B | EUR 1.2B | EUR 1.4B | EUR 1.4B |
| Free cash flow | EUR 6.9B | EUR 5.8B | EUR 8.2B | EUR 8.1B | EUR 6.9B |
Key ratios
| Fiscal year | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|
| Revenue growth (YoY) | – | 14.5% | −14.0% | 1.5% | −3.8% |
| Operating income growth (YoY) | – | 23.6% | −16.3% | −1.9% | 2.4% |
| Gross margin | 42.3% | 40.2% | 43.5% | 46.7% | 46.9% |
| Operating margin | 16.6% | 17.9% | 17.4% | 16.8% | 17.9% |
| Net margin | 12.6% | 13.8% | 13.8% | 12.1% | 19.8% |
| Return on equityBlank when equity is negative | 38.7% | 43.5% | 39.4% | 31.9% | 64.5% |
| ROCEEBIT ÷ (assets − current liabilities) | 17.3% | 20.5% | 17.4% | 16.2% | 18.5% |
| Free cash flow margin | 13.1% | 9.7% | 15.9% | 15.5% | 13.7% |
| Cash conversion (CFO ÷ net income) | 1.20x | 0.88x | 1.32x | 1.49x | 0.83x |
| Receivable days | 38 | 43 | 41 | 42 | 53 |
| Inventory days | 56 | 60 | 64 | 68 | 55 |
| Payable days | 179 | 183 | 211 | 218 | 231 |
| Interest cover | 17.7x | 13.1x | 9.76x | 8.88x | 8.83x |
| Current ratio | 0.70x | 0.75x | 0.76x | 0.76x | 0.79x |
Recent filings
More in Soap, Detergents, Cleang Preparations, Perfumes, Cosmetics
Standardised figures from the company's XBRL filings with the SEC (10-K, 10-Q). Line items follow US GAAP tags, so a company's own statement layout may differ and some lines show “–” where the company does not report that item. Ratios are calculated from these figures. For education only; not investment advice or a recommendation.